2022 annual financial data
ProQR Therapeutics 2022 Revenue growth
Direct answer
Revenue growth was 169.21%.
Operating income was -65,159,000 EUR and net income was -64,424,000 EUR.
Operating cash flow was -68,508,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,594,000 EUR
- Operating income
- -65,159,000 EUR
- Net income
- -64,424,000 EUR
- Operating cash flow
- -68,508,000 EUR